BackVascular Biogenics Overview

Vascular Biogenics Other Current Liabilities

Vascular Biogenics's other current liabilities is $-310K.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$-309000.00
106.74% YoYΔ $-4.89M vs prior year quarter

Peer average

Loading

Vascular Biogenics Other Current Liabilities History

Loading

Vascular Biogenics vs. peers: Other Current Liabilities Comparison

Loading

Vascular Biogenics Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vascular Biogenics (VBLT) FAQ

As of the most recent data (June 2024), VBLT shows a other current liabilities of $-310K. That compares with $4.6M in the prior-year period — down 106.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VBLT's other current liabilities is now $-310K (was $4.6M) — a 106.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Vascular Biogenics is outperforming or lagging.

Tracking VBLT's other current liabilities over time shows whether Vascular Biogenics is scaling, shrinking, or reshaping that part of the business. The current reading is $-310K That compares with $4.6M in the prior-year period — down 106.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Vascular Biogenics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $-310K) with ownership activity and broader fundamentals.

Vascular Biogenics's other current liabilities is $-310K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.